Wednesday, 5 October 2011

Anti-inflammatory drug 'reduces MS relapses'


Source  Boots WebMD:
5th October 2011 - Patients with MS who took the new generation anti-inflammatory medication natalizumab for two years had a lower risk of experiencing relapses and progression of their disability, according to a new study.  Read more here.